Spero Therapeutics (SPRO) Change in Acquisitions & Divestments (2018 - 2022)
Quarterly Change in Acquisitions & Divestments rose 143.27% to $49.9 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $49.9 million through Mar 2023, down 11.66% year-over-year, with the annual reading at $60.8 million for FY2022, 17.9% up from the prior year.
Spero Therapeutics filings provide 5 years of Change in Acquisitions & Divestments readings, the most recent being $49.9 million for Q2 2022.
- Change in Acquisitions & Divestments hit $49.9 million in Q2 2022 for Spero Therapeutics, up from $10.9 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $50.6 million in Q1 2019 and bottomed at $2.0 million in Q4 2020.
- Average Change in Acquisitions & Divestments over 5 years is $20.7 million, with a median of $18.3 million recorded in 2020.
- The largest annual shift saw Change in Acquisitions & Divestments crashed 85.61% in 2020 before it skyrocketed 351.2% in 2021.
- Spero Therapeutics' Change in Acquisitions & Divestments stood at $35.5 million in 2018, then tumbled by 76.03% to $8.5 million in 2019, then plummeted by 76.47% to $2.0 million in 2020, then surged by 250.0% to $7.0 million in 2021, then skyrocketed by 612.44% to $49.9 million in 2022.
- Per Business Quant, the three most recent readings for SPRO's Change in Acquisitions & Divestments are $49.9 million (Q2 2022), $10.9 million (Q1 2022), and $7.0 million (Q4 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Spero Therapeutics | 154.37 Mn | 98.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 49.87 Mn |
| Jun 30, 2022 | 49.87 Mn |
| Mar 31, 2022 | 10.91 Mn |
| Mar 31, 2022 | 10.91 Mn |
| Dec 31, 2021 | 7.00 Mn |
| Dec 31, 2021 | 7.00 Mn |
| Sep 30, 2021 | 18.05 Mn |
| Sep 30, 2021 | 18.05 Mn |
| Jun 30, 2021 | 20.50 Mn |
| Jun 30, 2021 | 20.50 Mn |
| Mar 31, 2021 | 6.00 Mn |
| Mar 31, 2021 | 6.00 Mn |
| Dec 31, 2020 | 2.00 Mn |
| Dec 31, 2020 | 2.00 Mn |
| Sep 30, 2020 | 4.00 Mn |
| Sep 30, 2020 | 4.00 Mn |
| Jun 30, 2020 | 18.50 Mn |
| Jun 30, 2020 | 18.50 Mn |
| Mar 31, 2020 | 31.85 Mn |
| Mar 31, 2020 | 31.85 Mn |
| Dec 31, 2019 | 8.50 Mn |
| Dec 31, 2019 | 8.50 Mn |
| Sep 30, 2019 | 27.80 Mn |
| Sep 30, 2019 | 27.80 Mn |
| Jun 30, 2019 | 31.95 Mn |
| Jun 30, 2019 | 31.95 Mn |
| Mar 31, 2019 | 50.59 Mn |
| Mar 31, 2019 | 50.59 Mn |
| Dec 31, 2018 | 35.46 Mn |
| Dec 31, 2018 | 35.46 Mn |
| Sep 30, 2018 | 9.00 Mn |
| Sep 30, 2018 | 9.00 Mn |